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Abstract
Background: Left ventricular hypertrophy (LVH) is a well known independent risk factor for
cardiovascular events. It has been shown that combination of left ventricular mass (LVM) and
relative wall thickness (RWT) can be used to identify different forms of left ventricular (LV)
geometry. Prospective studies have shown that LV geometric patterns have prognostic
implications, with the worst prognosis associated with concentric hypertrophy. The methods for
the normalization or indexation of LVM have also recently been shown to confer some prognostic
value especially in obese population. We sought to determine the prevalence of echocardiographic
lLVH using eight different and published cut-off or threshold values in hypertensive subjects seen
in a developing country's tertiary centre.
Methods: Echocardiography was performed in four hundred and eighty consecutive hypertensive
subjects attending the cardiology clinic of the University college Hospital Ibadan, Nigeria over a
two-year period.
Results: Complete data was obtained in 457 (95.2%) of the 480 subjects (48.6% women). The
prevalence of LVH ranged between 30.9–56.0%. The highest prevalence was when LVM was
indexed to the power of 2.7 with a partition value of 49.2 g/ht2.7 in men and 46.7 g/ht2.7 in women.
The lowest prevalence was observed when LVM was indexed to body surface area (BSA) and a
partition value of 125 g/m2 was used for both sexes. Abnormal LV geometry was present in 61.1%–
74.0% of our subjects and commoner in women.
Conclusion: The prevalence of LVH hypertensive patients is strongly dependent on the cut-off
value used to define it. Large-scale prospective study will be needed to determine the prognostic
implications of the different LV geometry in native Africans.
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Background
Left ventricular hypertrophy (LVH) either diagnosed by
electrocardiography or echocardiography is now well
known as an independent risk factor for cardiovascular
events. Echocardiographic LVH is diagnosed based on cut-
off values developed from population based studies in
which LV mass is indexed to body surface area (BSA),
height or height raised to the power of 2.7, the allometric
growth rate of the heart. Based on recent work by Koren et
al [1] and Ganau et al [2], combination of LVM and rela-
tive wall thickness (RWT) can now be used to identify dif-
ferent forms of LV geometry. Prospective studies have
shown that LV geometric patterns have prognostic impli-
cations, with the worst prognosis associated with concen-
tric hypertrophy [3]. The methods for the normalization
or indexation of LV mass have also recently been shown
to confer some prognostic value especially in obese popu-
lation [4,5].
Many studies have used different partition values for left
ventricular mass (LVM) in the classification of LV geome-
try. The purpose of this study is therefore to assess the
influence of various published partition values for LVM in
the diagnosis of LVH and LV geometry in native Africans.
Methods
The study was carried out at the Cardiology clinic of the
University College Hospital, Ibadan, Nigeria. It was an
observational cross-sectional study, which was conducted
within a two-year period. Hypertensive patients were eli-
gible for the study if they fulfilled the following criteria:
no evidence valvular abnormality (aortic or mitral value
disease) or congestive heart failure. Subjects with sickle
cell disease, diabetes mellitus, renal failure, and ischaemic
heart disease were also excluded from the study. Both
treated and untreated hypertensive subjects were
recruited.
All the subjects gave informed consent before they were
enrolled into the study. Ethical clearance was obtained
from the joint University of Ibadan and University Col-
lege Hospital Ibadan ethical committee.
Clinical evaluation
Baseline clinical and demographic characteristics were
obtained from the subjects. These included date of birth,
age, gender, history of diabetes, and history of smoking
and alcohol use. Blood pressure measurements were
obtained according to standard guidelines with a mercury
sphygmomanometer (Accosson London). Systolic and
diastolic blood pressures were measured at Korotkoff
sounds phases I and V respectively. Blood pressure was
measured at the right arm three (3) times and averaged
after a 5 minutes rest. Blood pressure 140/90 and above
was taken as hypertension[6]. Subjects were weighed
without shoes and in light clothing on a standard beam
balance. Height was measured to the nearest centimetre
using anthropometrical plane with subjects not putting
on shoes or headgear. Body mass index (BMI) was calcu-
lated using the formula: BMI = Weight (kg)/(height).
Body surface area (BSA) was calculated using the formula
of Dubois.[7]
Echocardiography
M-mode, 2D and Doppler echocardiography were per-
formed using a standard protocol and an ALOKA SSD
echocardiography machine (Aloka Co. Ltd., Tokyo,
Japan). Two dimensional guided M- mode measurements
were made according to the recommendations of the
American Society of Echocardiography (ASE)[8]. LV inter-
nal dimension, posterior wall thickness and interventricu-
lar septal thickness were measured at end-diastole and
end-systole. Where optimal M-mode imaging could not
be obtained, 2D linear measurements were obtained
according to the ASE criteria [8]. Left atrial end systolic
diameter was obtained from the trailing edge of the poste-
rior aortic – anterior left atrial complex. Measurements
were obtained in up to 3 cardiac cycles according to the
ASE convention [8]. Two experienced physicians per-
formed the echocardiography. In our laboratory, the
intra-observer concordance correlation coefficient ranged
from 0.76 to 0.98 while that of the inter-observer con-
cordance ranged from 0.82 to 0.96[9]
Calculation of derived variables
Left ventricular mass was calculated using the formula of
Devereux and Reichek.[10] This has been shown to yield
LVM closely related to autopsy measurements (r =
0.90)[11] and has good interobserver reproducibility (ρ =
0.93) in one study[12]. Relative wall thickness (RWT) was
derived from 2 X posterior wall thickness/LV internal
diameter. Increased RWT was considered to be present
when RWT exceeded 0.43. This represents the 97.5th per-
centile in normal subjects [13].
We assessed left ventricular hypertrophy using various
published partition values.
Partition values for LVM normalized for BSA were:
 125 g/m2 for both men and women[1],
 116 g/m2 for men and 104 g/m2 for women[14],
 125/m2 for men and 110 g/m2 for women[15],
 131 g/m2 for men and 100 g/m2 for women[16].
Partition values for LVM indexed for height were:BMC Medical Imaging 2006, 6:10 http://www.biomedcentral.com/1471-2342/6/10
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 126 g/m for men and 105 g/m for women[17]
 143 g/m for men and 102 g/m for women[16],
Values for LVM raised to the allometric growth rate of 2.7
were:
 51 g/m2.7 for both men and women[17]
 49.2 g/m2.7 for men and 46.7 g/m2.7 for women[17]
Left ventricular geometric was defined as follows: Normal
geometry, when LVMI and RWT were normal; Concentric
remodeling, when LVMI was normal and RWT increased;
Eccentric hypertrophy, when LVMI was increased but nor-
mal RWT; and Concentric hypertrophy, when both LVMI
and RWT were increased [2].
Statistical analysis
SPSS version 11.0 software (SPSS, Chicago, IL, USA) was
used in the analysis of the data. Continuous variables
were expressed as mean ± SD while categorical variables
were expressed as counts (percentages). Normality of con-
tinuous variables was assessed using the Kolmogorov-
Smirnov statistics. Comparison between two groups was
assessed by the Students t- test for independent variables
while the χ2 analysis was used to compare proportions. A
2-tailed p-value of 0.05 was assumed statistically signifi-
cant.
Results
Clinical characteristics
The clinical characteristic of our study subjects is as shown
in Table 1. A total of four hundred and eighty hyperten-
sive subjects who met the inclusion criteria were recruited
for the study. Twenty three (23) subjects were dropped
from the final analysis because of incomplete data or
inadequate echocardiogram. Four hundred and fifty seven
subjects were included in the analysis (95.2%). These
were two hundred and thirty five (235) men and two hun-
dred and twenty two (222) women constituting 51.4%
and 48.6% respectively. The mean ages for men and
women were similar (56.0 ± 13.0 vs 55.5 ± 13.5, p =
0.672). The men were taller and had a greater body surface
area than the women (P < 0.0001). Clinic blood pressures
were similar in both sexes.
Echocardiographic measurements
Table 2 shows the echocardiographic measurements in
the subjects. The echocardiographic LV parameters were
generally higher in men than in women except for the
indexes of LV systolic function.
Table 3 depicts the prevalence of left ventricular hypertro-
phy and abnormal LV geometry in the hypertensive sub-
jects. The prevalence of left ventricular hypertrophy based
on LVM above the threshold value ranged between 30.9%
and 56%. The lowest prevalence is when LVM was
indexed to BSA and a partition value of 125 g/m2 was used
for both sexes. Highest prevalence occurred when LVM
was indexed to height raised to the power of 2.7 and par-
tition value of 49.2 g/ht2.7 in men and 46.7 g/ht 2.7 in
women. The prevalence of abnormal LV geometry ranged
from 61.1% to 74%.
Table 4 shows the distribution of LV Geometry according
to gender. Abnormal LV geometry is significantly higher
in women than men except when LVM was indexed to
height2.7 with a partition value of 51 g/height2.7 for both
sexes.
Discussion
It is now well established that LVH either determined by
electrocardiography or echocardiography is a strong pre-
dictor of poor prognosis in cardiovascular disorders inde-
pendent of traditional risk factors. Various authors have
used different partition values to define increased LVM.
This includes BSA [18], BSA raised to the power of 1.5;
height, height raised to the power of 2.0, 2.13, 2.7[17] and
3.0. Furthermore, combination of indexed LVM and RWT
has been used to define geometry.
This study is the first to look at the impact of various cut-
off values for LVM on the prevalence of LVH and abnor-
mal LV geometry in hypertensive native Africans.
Our study shows that the prevalence of LVH ranges
between 30.9–56.0%. We also observed that the highest
prevalence was when LVM was indexed to the power of
2.7 with a partition value of 49.2 g/ht2.7 in men and 46.7
g/ht2.7 in women. The lowest prevalence was observed
when LVM was indexed to BSA and a partition value of
125 g/m2 was used for both sexes. We also report that
abnormal LV geometry is present in 61.1%–74.0% of our
subjects. Eccentric LV geometry was the commonest
abnormal geometry in our hypertensive population
(17.5–30.4%) while concentric LV geometry was present
in 3.3–25.6% of the subjects. Normal geometry was seen
in 26–38.9%. Abnormal geometry was more common in
women in all the partition values.
Our finding is similar to those of other workers. Wachtell
and his colleagues [19] in the LIFE multi-centre study
group studied 941 stage I-III hypertensive subjects. They
reported a 42–78% prevalence of LVH and 63–86% prev-
alence of abnormal LV geometry. Fifteen to forty percent
(15–40%) of their subjects had normal geometry. Eccen-
tric LV geometry was also the commonest abnormal LV
geometry in their study.BMC Medical Imaging 2006, 6:10 http://www.biomedcentral.com/1471-2342/6/10
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In a cross-sectional study, Coca et al studied 946 hyperten-
sive subjects recruited randomly from thirty nine (39) pri-
mary health care centres in Spain. They reported a 59.2–
72.7% prevalence of LVH depending on the criteria used.
They also noted that the prevalence of LVH was higher in
men using the Framingham criteria but higher in women
using de Simone et al criteria. Eccentric LVH was the com-
monest abnormal criteria in their study (51.3–54.1%)
independent of the criteria used. Normal geometry was
seen in 20.8–29.7% of their subjects. Overall, 70.3–
79.2% of their hypertensive subjects had abnormal geom-
etry.
Cuspidi and his co-workers[20], using six different
echocardiographic criteria, studied 611 consecutive
hypertensive subjects in Italy. The prevalence of LVH in
their study was 18.6–42.7%. Eccentric LV geometry was
commonest and abnormal LV geometry was more com-
mon in women than the men. They also observed that
LVM correlated positively well with BSA, height, and
height2.7 and carotid intima-media thickness.
Three groups studied the influence of different partition
values on the prevalence of LVH in newly diagnosed
untreated hypertensive subjects.
In the study of 165 untreated essential hypertensive sub-
jects by Ganau et al[2], 52% of their subjects had normal
geometry, 13% had concentric remodeling, 27% had
eccentric hypertrophy while only 8% had the "typical"
hypertensive left ventricular hypertrophy. Furthermore,
they documented that systemic hemodynamics paralleled
ventricular geometry, with the highest peripheral resist-
ance in the groups with concentric remodeling and hyper-
trophy, whereas cardiac index was super-normal in those
with eccentric hypertrophy and low normal in patients
with concentric remodeling[2].
Gosse et al[21] studied 363 untreated patients using three
partition values. They reported the prevalence of LVH as
48.2–50.4%. The authors concluded that a cut-off value of
53 g/m2.7 in men and 47 g/m2.7 in women corresponded
to a cardiovascular risk indicated by daytime systolic BP
Table 1: Baseline clinical and demographic characteristics
Parameter All Subjects
N = 457
Men
N = 235(51.4%)
Women
N = 222(48.6%)
P-value
Age (yrs) 55.8 ± 13.3 56.0 ± 13.0 55.5 ± 13.5 0.672
Weight (kg) 73.1 ± 13.7 71.4 ± 13.5 74.8 ± 13.7 0.009
Height (cm) 164.3 ± 8.3 169.1 ± 6.9 159.3 ± 6.5 <0.0001
Body Mass Index (kg/m2) 27.1 ± 4.8 26.1 ± 4.4 28.1 ± 5.0 <0.0001
Body Surface Area (m2) 1.79 ± 0.18 1.85 ± 0.17 1.74 ± 0.16 <0.0001
Heart Rate (beats/min) 80.4 ± 16.7 80.2 ± 17.3 80.6 ± 16.1 0.774
Systolic Blood Pressure (mmHg) 142.7 ± 20.8 142.8 ± 21.0 142.7 ± 20.7 0.986
Diastolic Blood Pressure (mmHg) 88.3 ± 12.9 88.1 ± 12.8 88.5 ± 13.0 0.714
Pulse Pressure (mmHg) 54.3 ± 16.8 54.7 ± 17.8 54.0 ± 15.7 0.648
Mean Arterial Pressure (mmHg) 106.2 ± 14.8 106.3 ± 13.6 106.1 ± 15.9 0.887
%Overweight 27.8% 19.1% 36.9% <0.0001
Table 2: Echocardiographic parameters
Parameter All Subjects
N = 457
Men
N = 235
Women
N = 222
P-value
Aorta (cm) 2.90 ± (0.43) 3.06 ± 0.42 2.74 ± 0.37 <0.0001
Left Atrium (cm) 3.51 ± (0.65) 3.59 ± 0.67 3.42 ± 0.62 0.004
IVSTd (cm) 1.04 ± (0.18) 1.08 ± 0.17 1.00 ± 0.18 <0.0001
PWTd (cm) 1.00 ± (0.19) 1.01 ± (0.17) 0.98 ± 0.20 0.55
LVEDD (cm) 4.82 ± 0.91 5.08 ± 0.96 4.54 ± 0.75 0.0001
LVESD (cm) 3.26 ± (0.95) 3.49 ± 1.04 3.01 ± 0.77 0.001
FS (%) 33.5 ± 8.1 32.7 ± 8.07 34.4 ± 8.13 0.032
EF (%) 69.4 ± 10.7 68.4 ± 10.9 70.3 ± 10.4 0.059
IVSTd= interventricular Septal Thickness in Diastole, PWTd= Posterior Wall Thickness in Diastole, LVEDD= Left Ventricular End-Diastolic 
Diameter, LVESD= Left Ventricular End-Systolic Diameter, FS= Fractional Shortening, EF= Ejection FractionBMC Medical Imaging 2006, 6:10 http://www.biomedcentral.com/1471-2342/6/10
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>= 135 mmHg. Another study reported a prevalence of 9–
25% in newly diagnosed hypertensive subjects [22].
Similar to the observation of Wachtell et al, most of the
criteria yielded unequal distribution of abnormal LV
geometry between men and women in our study. But
unlike their finding (where four criteria gave similar dis-
tribution in men and women), only one criterion gave
similar distribution in men and women (LVM/ht2.7 with a
partition value of 51 g/ht2.7 in both men and women). All
the other criteria gave higher prevalence of abnormal LV
geometry in women than in men. This is similar to the
observations by Wachtell et al[19]. The most plausible
reason for this is that the men in this study generally had
larger BSA and were taller than their female counterparts.
The later are however heavier and have larger BMI as
noted in the baseline characteristics of the subjects in this
study and in our previous reports[9].
Two recent publications have compared the prognostic
implications of different normalization for LVH. Report
from the Strong Heart Study group showed that the pres-
ence of LVH identified by LV mass normalized for height
to allometric powers is associated with higher incident
cardiovascular events than is LVH detected by normaliza-
tion for body surface area[5]. In the second study con-
Table 4: Distribution of LV geometry according to gender
Partition value Normal geometry
M/F
Concentric remodeling
M/F
Eccentric Hypertrophy
M/F
Concentric hypertrophy
M/F
P-value
LVM/BSA
M/F = 116/104
84/49 73/30 34/91 31/65 <0.0001
LVM/BSA
M/F = 125/125
94/84 83/55 24/56 21/40 <0.0001
LVM/BSA
M/F = 125/110
94/65 83/35 24/75 21/60 <0.0001
LVM/BSA
M/F = 131/110
95/43 85/26 23/97 19/69 <0.0001
LVM/HT
M/F = 143/102
90/31 87/19 28/109 17/76 <0.0001
LVM/HT
M/F = 126/105
85/35 73/22 33/105 31/73 <0.0001
LVM/HT2.7
M/F = 49.2/46.7
64/55 54/28 54/85 50/67 0.0011
LVM/HT2.7
M/F = 51/51
69/71 58/48 49/69 46/47 0.261
LV = Left Ventricular, LVM = Left Ventricular Mass, BSA = Body Surface Area, HT = Height, M/F = Male/Female
Table 3: LV geometric patterns according to partition value
PARTITION 
VALUE
LVH/NO LVH %LVM NORMAL 
GEOMETRY (i)
CONCENTRIC 
REMODELLING (ii)
ECCENTRIC 
HYPERTROPHY 
(iii)
CONCENTRIC 
HYPERTROPHY 
(iv)
%ABNORMAL 
LV- GEOMETRY 
(ii + iii + iv)
LVM/BSA
M/F = 116/104
221/236 48.4 133(29.1%) 103(22.5%) 125(27.4%) 96(21.0%) 70.9
LVM/BSA
M/F = 125/125
141/316 50.3 178(38.9%) 138(30.2%) 80(17.5%) 61(13.4%) 73.5
LVM/BSA
M/F = 125/110
180/277 56 159(34.9%) 118(25.8%) 99(21.7%) 81(17.6%) 74
LVM/BSA
M/F = 131/110
208/249 30.9 138(30.2%) 111(24.3%) 120(26.3%) 88(19.1%) 61.1
LVM/HT
M/F = 143/102
230/227 39.4 121(26.5%) 106(23.2%) 137(30.0%) 93(20.3%) 65.2
LVM/HT
M/F = 126/105
242/215 45.5 120(26.2%) 95(20.8%) 138(30.2%) 104(22.8%) 69.8
LVM/HT2.7
M/F = 49.2/46.7
256/201 53 119(26.1%) 82(17.9%) 139(30.4%) 117(25.6%) 73.7
LVM/HT2.7
M/F = 51/51
211/246 46.2 140(30.6%) 106(23.2%) 118(25.8%) 93(20.4%) 69.4
LV = Left Ventricular, LVM = Increased Left Ventricular Mass, BSA = Body Surface Area, HT = Height, M/F = Male/Female.BMC Medical Imaging 2006, 6:10 http://www.biomedcentral.com/1471-2342/6/10
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ducted in a population of hypertensive subjects with low
prevalence of obesity, population risk attributable to LV
hypertrophy was similar for height as well as body surface
area based partition values [4]. Large scale prospective
study similar to these will surely be required in defining
the prognostic implications of different LV geometry in
native Africans.
Limitations
The subjects used for this single centre cross-sectional
study were unselected in terms of whether on treatment or
not. Similar study will therefore be necessary in newly
diagnosed untreated hypertensive Nigerians.
Conclusion
LVH by echocardiography is present in 30.9–56.0% of
hypertensive Nigerian seen in tertiary health care setting.
Abnormal LV geometry is found in 61.1–74.0% of the
subjects. Eccentric LV geometry is the commonest abnor-
mal LV geometry in our subjects. Abnormal LV geometry
is commoner in women and unevenly distributed in men
and women except when the partition value of 51 g/ht2.7
was used for both gender.
Partition values are strongly population dependent since
they are derived from reference normal subjects. Different
methods of indexation lead to different prevalence of LVH
because the LV mass is looked at from different point of
view. For example indexation to BSA offsets the independ-
ent impact of obesity on LV mass while indexation for
height (especially when indexed to height raised to the
power of 2.7) is useful in the definition of "genetically
determined" LV mass.
Large scale prospective study will be needed to determine
the prognostic implications of the different LV geometry
in native Africans. We also intend to define which method
of indexation is more reliable in our population through
future prospective studies.
Competing interests
The author(s) declare that they have no competing inter-
ests.
Authors' contributions
AAA, OSO and AA conceived of the study and participated
in the study design. OSO drafted the manuscript, AAA and
OSO carried out the statistical analysis. OOO took part in
the study design and study conception. DBO and AKA
participated in the study design and data acquisition. AOF
conceived of the study and participated in the study
design. All authors read and approved the final manu-
script.
Acknowledgements
We acknowledge Mrs. K.A Ogunrinde, A.O. Adegbola, O.B. Adubi and Miss 
H.M. Elutifaju of the ECG/ECHO Unit of University College Hospital, 
Ibadan for their invaluable assistance.
Source of funding: None
References
1. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH: Relation
of left ventricular mass and geometry to morbidity and mor-
tality in uncomplicated essential hypertension.  Ann Intern Med
1991, 114:342.
2. Ganau A, Devereux RB, Roman MJ, de Simone G, Pickering TG, Saba
PS, Vargiu P, Simongini I, Laragh JH: Patterns of left ventricular
hypertrophy and geometric remodeling in essential hyper-
tension.  J Am Coll Cardiol 1992, 19(7):1550-1558.
3. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Gattobigio R, Zampi
I, Santucci A, Santucci C, Reboldi G, Porcellati C: Prognostic value
of left ventricular mass and geometry in systemic hyperten-
sion with left ventricular hypertrophy.  Am J Cardiol 1996,
78(2):197-202.
4. de Simone G, Devereux RB, Maggioni AP, Gorini M, de Divitiis O,
Verdecchia P: Different normalizations for body size and pop-
ulation attributable risk of left ventricular hypertrophy: the
MAVI study.  Am J Hypertens 2005, 18(10):1288-1293.
5. de Simone G, Kizer JR, Chinali M, Roman MJ, Bella JN, Best LG, Lee
ET, Devereux RB: Normalization for body size and population-
attributable risk of left ventricular hypertrophy: the Strong
Heart Study.  Am J Hypertens 2005, 18(2 Pt 1):191-196.
6. World Health Organisation-International Society of Hyper-
tension guidelines for the management of hypertension.
Guideline Subcommitee.  J Hypertens 1999, 17:151-183.
7. Dubois D, Dubois EF: A formula to estimate the approximate
surface area if height and weight be known.  Arch Intern Med
1916, 17:863-871.
8. Sahn DJ, DeMaria A, Kisslo J, Weyman A: Recommendations
regarding Quantitation in M-mode Echocardiography.
Results of a survey of Echocardiographic measurements.  Cir-
culation 1978, 56:1072-1083.
9. Adebiyi AA, AJE A, Ogah OS, Ojji DB, Dada A, Oladapo O, Falase
AO: Correlates of left atrial size in Nigerian hypertensives.
Cardiovasc J South Afr 2005, 16(3):201-204.
10. Devereux RB, Reichek N: Echocardiographic determination of
LVM in man:anatomic validation of the method.  Circulation
1977, 5:613-618.
11. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I,
Reichek N: Echocardiographic assessment of left ventricular
hypertrophy:comparison to necropsy findings.  Am j Cardiol
1986, 57:450-458.
12. Palmieri V, Dahlof B, De Quattro V, Sharpe N, Bella JN, de Simone G,
Paranicas M, Fishman D, Devereux RB: Reliability of echocardio-
graphic assessment of left ventricular structure and function.
The PRESERVE study.  J Am Coll Cardiol 1999, 34:1625-1632.
13. Roman MJ, Pickering TG, Schwartz JE, Pini R, Devereux RB: Associ-
ation of carotid atherosclerosis and left ventricular hyper-
trophy.  J Am Coll Cardiol 1995, 25(1):83-90.
14. Devereux RB, Dahlof B, Levy D, Pfeffer MA: Comparison of enal-
april versus nifedipine to decrease left ventricular hypertro-
phy in systemic hypertension (the PRESERVE trial).  Am J
Cardiol 1996, 78(1):61-65.
15. Hammond IW, Devereux RB, Alderman MH, Lutas EM, Spitzer MC,
Crowley JS, Laragh JH: The prevalence and correlates of
echocardiographic left ventricular hypertrophy among
employed patients with uncomplicated hypertension.  J Am
Coll Cardiol 1986, 7(3):639-650.
16. Levy D, Savage DD, Garrison RJ, Anderson KM, Kannel WB, Castelli
WP: Echocardiographic criteria for left ventricular hypertro-
phy: the Framingham Heart Study.  Am J Cardiol 1987,
59(9):956-960.
17. de Simone G, Devereux RB, Daniels SR, Koren MJ, Meyer RA, Laragh
JH: Effect of growth on variability of left ventricular mass:
assessment of allometric signals in adults and children and
their capacity to predict cardiovascular risk.  J Am Coll Cardiol
1995, 25(5):1056-1062.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Medical Imaging 2006, 6:10 http://www.biomedcentral.com/1471-2342/6/10
Page 7 of 7
(page number not for citation purposes)
18. Ghali JK, Liao Y, Simmons B, Castaner A, Cao G, Cooper RS: The
prognostic role of left ventricular hypertrophy in patients
with or without coronary artery disease.  Ann Intern Med 1992,
117(10):831-836.
19. Wachtell K, Bella JN, Liebson PR, Gerdts E, Dahlof B, Aalto T, Roman
MJ, Papademetriou V, Ibsen H, Rokkedal J, et al.: Impact of different
partition values on prevalences of left ventricular hypertro-
phy and concentric geometry in a large hypertensive popula-
tion : the LIFE study.  Hypertension 2000, 35(1 Pt 1):6-12.
20. Cuspidi C, Lonati L, Macca G, Sampieri L, Fusi V, Michev I, Severgnini
B, Salerno M, Magrini F, Zanchetti A: Prevalence of left ventricu-
lar hypertrophy and carotid thickening in a large selected
hypertensive population: impact of different echocardio-
graphic and ultrasonographic diagnostic criteria.  Blood Press
2001, 10(3):142-149.
21. Gosse P, Jullien V, Jarnier P, Lemetayer P, Clementy J: Echocardio-
graphic definition of left ventricular hypertrophy in the
hypertensive: which method of indexation of left ventricular
mass?  J Hum Hypertens 1999, 13(8):505-509.
22. Cuspidi C, Macca G, Sampieri L, Michev I, Fusi V, Salerno M, Sev-
ergnini B, Corti C, Magrini F, Zanchetti A: Influence of different
echocardiographic criteria for detection of left ventricular
hypertrophy on cardiovascular risk stratification in recently
diagnosed essential hypertensives.  J Hum Hypertens 2001,
15(9):619-625.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-2342/6/10/prepub